Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2808.0
(2.3%)
JPY 2808.0
(2.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 172.7 Billion JPY | 16.06% |
| 2022 | 148.8 Billion JPY | 33.7% |
| 2021 | 111.29 Billion JPY | 79.95% |
| 2020 | 61.85 Billion JPY | -2.87% |
| 2019 | 63.68 Billion JPY | 57.95% |
| 2018 | 40.31 Billion JPY | -29.2% |
| 2017 | 56.94 Billion JPY | 1.74% |
| 2016 | 55.97 Billion JPY | 40.69% |
| 2015 | 39.78 Billion JPY | 87.39% |
| 2014 | 21.23 Billion JPY | 30.11% |
| 2013 | 16.31 Billion JPY | 13.82% |
| 2012 | 14.33 Billion JPY | 42.69% |
| 2011 | 10.04 Billion JPY | 1111.94% |
| 2010 | 829 Million JPY | 112.5% |
| 2009 | -6.63 Billion JPY | -127.76% |
| 2008 | -2.91 Billion JPY | -284.75% |
| 2007 | -757.04 Million JPY | -76.15% |
| 2006 | -429.76 Million JPY | -13.94% |
| 2005 | -377.17 Million JPY | -217.19% |
| 2004 | 321.85 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 178.08 Billion JPY | 3.11% |
| 2023 Q4 | 172.7 Billion JPY | 4.37% |
| 2023 Q3 | 165.47 Billion JPY | 3.16% |
| 2023 FY | 172.7 Billion JPY | 16.06% |
| 2023 Q2 | 160.39 Billion JPY | 6.76% |
| 2023 Q1 | 150.23 Billion JPY | 0.96% |
| 2022 Q2 | 118.67 Billion JPY | 3.72% |
| 2022 Q3 | 129.69 Billion JPY | 9.28% |
| 2022 Q4 | 148.8 Billion JPY | 14.74% |
| 2022 FY | 148.8 Billion JPY | 33.7% |
| 2022 Q1 | 114.42 Billion JPY | 2.81% |
| 2021 Q2 | 55.28 Billion JPY | -6.63% |
| 2021 Q1 | 59.21 Billion JPY | -4.26% |
| 2021 FY | 111.29 Billion JPY | 79.95% |
| 2021 Q4 | 111.29 Billion JPY | 87.32% |
| 2021 Q3 | 59.41 Billion JPY | 7.47% |
| 2020 FY | 61.85 Billion JPY | -2.87% |
| 2020 Q1 | 65.89 Billion JPY | 3.48% |
| 2020 Q2 | 60.28 Billion JPY | -8.51% |
| 2020 Q3 | 67.06 Billion JPY | 11.25% |
| 2020 Q4 | 61.85 Billion JPY | -7.78% |
| 2019 FY | 63.68 Billion JPY | 57.95% |
| 2019 Q4 | 63.68 Billion JPY | 105.31% |
| 2019 Q3 | 31.01 Billion JPY | -1.75% |
| 2019 Q2 | 31.57 Billion JPY | -24.9% |
| 2019 Q1 | 42.03 Billion JPY | 4.27% |
| 2018 Q3 | 45.9 Billion JPY | -7.88% |
| 2018 Q4 | 40.31 Billion JPY | -12.17% |
| 2018 FY | 40.31 Billion JPY | -29.2% |
| 2018 Q1 | 48.59 Billion JPY | -14.67% |
| 2018 Q2 | 49.83 Billion JPY | 2.56% |
| 2017 Q1 | 46.55 Billion JPY | -16.83% |
| 2017 FY | 56.94 Billion JPY | 1.74% |
| 2017 Q4 | 56.94 Billion JPY | 3.17% |
| 2017 Q3 | 55.19 Billion JPY | 10.8% |
| 2017 Q2 | 49.81 Billion JPY | 7.02% |
| 2016 Q3 | 42.06 Billion JPY | 6.05% |
| 2016 FY | 55.97 Billion JPY | 40.69% |
| 2016 Q1 | 40.9 Billion JPY | 2.82% |
| 2016 Q4 | 55.97 Billion JPY | 33.07% |
| 2016 Q2 | 39.66 Billion JPY | -3.04% |
| 2015 Q1 | 22.24 Billion JPY | 4.78% |
| 2015 Q2 | 37.7 Billion JPY | 69.5% |
| 2015 Q3 | 39.71 Billion JPY | 5.33% |
| 2015 Q4 | 39.78 Billion JPY | 0.18% |
| 2015 FY | 39.78 Billion JPY | 87.39% |
| 2014 Q4 | 21.23 Billion JPY | 18.5% |
| 2014 Q3 | 17.91 Billion JPY | 7.97% |
| 2014 Q2 | 16.59 Billion JPY | 6.96% |
| 2014 FY | 21.23 Billion JPY | 30.11% |
| 2014 Q1 | 15.51 Billion JPY | -4.93% |
| 2013 Q2 | 13.4 Billion JPY | 6.13% |
| 2013 FY | 16.31 Billion JPY | 13.82% |
| 2013 Q3 | 14.99 Billion JPY | 11.81% |
| 2013 Q4 | 16.31 Billion JPY | 8.85% |
| 2013 Q1 | 12.63 Billion JPY | -11.88% |
| 2012 FY | 14.33 Billion JPY | 42.69% |
| 2012 Q4 | 14.33 Billion JPY | -1.47% |
| 2012 Q3 | 14.55 Billion JPY | 9.7% |
| 2012 Q2 | 13.26 Billion JPY | -4.56% |
| 2012 Q1 | 13.89 Billion JPY | 38.32% |
| 2011 FY | 10.04 Billion JPY | 1111.94% |
| 2011 Q2 | 5 Billion JPY | -5.8% |
| 2011 Q3 | 8.42 Billion JPY | 68.35% |
| 2011 Q1 | 5.31 Billion JPY | 540.53% |
| 2011 Q4 | 10.04 Billion JPY | 19.31% |
| 2010 Q1 | -3.16 Billion JPY | 52.29% |
| 2010 Q4 | 829 Million JPY | 135.13% |
| 2010 FY | 829 Million JPY | 112.5% |
| 2010 Q2 | -3.34 Billion JPY | -5.78% |
| 2010 Q3 | -2.36 Billion JPY | 29.51% |
| 2009 FY | -6.63 Billion JPY | -127.76% |
| 2009 Q2 | -4.18 Billion JPY | -98.64% |
| 2009 Q3 | -4.69 Billion JPY | -12.18% |
| 2009 Q4 | -6.63 Billion JPY | -41.3% |
| 2009 Q1 | -2.1 Billion JPY | 27.67% |
| 2008 Q4 | -2.91 Billion JPY | -209.54% |
| 2008 FY | -2.91 Billion JPY | -284.75% |
| 2008 Q3 | -940.99 Million JPY | 0.0% |
| 2007 FY | -757.04 Million JPY | -76.15% |
| 2006 FY | -429.76 Million JPY | -13.94% |
| 2005 FY | -377.17 Million JPY | -217.19% |
| 2004 FY | 321.85 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -13998.449% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 96.062% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 55.698% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 149.847% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 4945.687% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 509.683% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 380.942% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 276.353% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 25992.954% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 433.274% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 624.607% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | -2171.85% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | -2119.586% |
| Tsumura & Co. | 1.61 Billion JPY | -10593.87% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 491.091% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 601.513% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | -548.685% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | -495.913% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | -2346.261% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -24432.102% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -2782.276% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 2750.082% |
| MedRx Co., Ltd | -1.72 Billion JPY | 10141.047% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 2081.377% |
| Solasia Pharma K.K. | -668 Million JPY | 25954.192% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 11841.223% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 2481.166% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | -205.555% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 5933.139% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 275.463% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 1651.772% |